News

The recall has been given a Class II classification, indicating there is a significant level of risk posed to consumers in ...
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...
Food and Drug Administration Commissioner Marty Makary said in a recent interview he has no plans to change policies regarding the abortion pill mifepristone.
The strategic reprioritization comes after the company hit two major hurdles in the past year, including a clinical hold for ...
Last week, the FDA had issued a warning about a “Dubai chocolate” spread available in US markets after it tested positive for ...
There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...
Roche’s move came against a backdrop of wider industry retreat from gene therapy, with Pfizer pulling its FDA-approved ...
If you collect the data today, what can you read from it five years from now because the technology is advancing so quickly?” ...
Proceeds to Fund Completion of the Company’s 510k Filing with the U.S. FDA for its Fingerprint Drug Screening System ...
Beyond Air, Inc. (NASDAQ: XAIR) ('Beyond Air” or the 'Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the ...
An expert discusses how optimal sequencing of therapies remains unclear in lower-risk MDS, with emerging combination ...
European regulators have greenlit a twice-yearly injection to prevent HIV that has been hailed as a game-changer in the ...